Skip to content
TrialMatch
Sign up
Recruiting

Imaging Biomarkers in Preclinical and Symptomatic AD

Create a profile to match View the full record on ClinicalTrials.gov

About this study

The purpose of this research study is to evaluate adult children of parents with and without Alzheimer's disease which represent an ideal population for investigating the biological changes that precede the clinical onset of AD. The investigators will be imaging the brain to detect the presence of amyloid deposits (plaques in the brain). Amyloid is a protein that may be related to dementia of Alzheimer's disease (DAT).

Condition
Alzheimer Disease
Tested
[11C] Pittsburgh Compound-B (PIB)
Sponsor
Tammie L. S. Benzinger, MD, PhD

Who can join

Age
18 years and older
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 5

  • Minimum age: 18 years
  • Study condition: Alzheimer Disease
  • Male or female, any race;
  • Age ≥ 18 years;
  • Active participants currently enrolled in the Knight Alzheimer's Disease Research Center (ADRC) at Washington University.

Exclusion 8

  • Hypersensitivity to \[11C\] PIB or any of its excipients;
  • Contraindications to PET, CT or MRI (e.g. electronic medical devices, inability to lie still for extended periods) that make it unsafe for the individual to participate;
  • Severe claustrophobia;
  • Women who are pregnant or breast-feeding will be excluded from PIB PET participation;
  • Has any condition that, in the opinion of the Sponsor-Investigator or designee could increase risk to the subject, limit the subject's ability to tolerate the research procedures, or interfere with collection of the data;
  • Currently participating in any clinical trial which involves an active study medication or placebo within the past 30 days before scanning and up to 2-weeks past the imaging visit.
  • Current or recent (within 12 months prior to screening) participation in research studies involving radioactive agents such that the total research-related radiation dose to the participant in any given year would exceed the limits set forth in the U.S.
  • Code of Federal Regulations (CFR) Title 21 Section 361.1. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?FR=361.1

Where

1 site, 1 recruiting

Washington University School of Medicine

St Louis, Missouri, United States

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.